|
Index of reports
> Cases with Infection (86)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 86 Next >>
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-14
Patient:
Reactions: Transplant Failure, Cardiac Failure, Myelodysplastic Syndrome, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Indication: Mantle Cell Lymphoma
Cytarabine
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Indication: Mantle Cell Lymphoma
Etoposide
Indication: Mantle Cell Lymphoma
Mabthera
Indication: Mantle Cell Lymphoma
Melphalan Hydrochloride
Indication: Mantle Cell Lymphoma
Prednisolone
Indication: Mantle Cell Lymphoma
Vincristine
Indication: Mantle Cell Lymphoma
Possible Prednisolone side effects in
Reported by a physician from Denmark on 2012-08-06
Patient:
Reactions: Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Carmustine
Dosage: on day 1; beam/c
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: day 1; cycle 5; chop regimen
Indication: Mantle Cell Lymphoma
Cyclophosphamide
Dosage: day 1; cycle 1; chop regimen
Cyclophosphamide
Dosage: day 2-5 in beac regimen
Cyclophosphamide
Dosage: day 1; cycle 3; chop regimen
Cytarabine
Dosage: 3 or 2 g/m2, four-3 hour infusions; cycle 4
Indication: Mantle Cell Lymphoma
Cytarabine
Dosage: 3 or 2 g/m2, four-3 hour infusions; cycle 2
Cytarabine
Dosage: day 2-5 in beam or beac regimen
Cytarabine
Dosage: 3 or 2 g/m2, four-3 hour infusions; cycle 6
Doxorubicin HCL
Dosage: on day 1; cycle 3
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1; cycle 1
Doxorubicin HCL
Dosage: on day 1; cycle 5
Etoposide
Dosage: day 2- 5; beam/c regimen
Indication: Mantle Cell Lymphoma
Melphalan Hydrochloride
Dosage: on day 6; beam regimen
Indication: Mantle Cell Lymphoma
Prednisolone
Dosage: on day 1-5; cycle 1
Prednisolone
Dosage: on day 1-5; cycle 3
Prednisolone
Dosage: on day 1-5; cycle 5
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: day 1 cycle 5
Rituximab
Dosage: day1 cycle 6, also given on day 9 for in-vivo purging
Rituximab
Dosage: day 1 from cycle 4
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 ; cycle 5
Vincristine
Dosage: on day 1; cycle 1
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1; cycle 3
Possible Prednisolone side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Prednisolone side effects in
Reported by a physician from Japan on 2012-07-17
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Rituxan
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Prednisolone side effects in female
Reported by a physician from Japan on 2012-07-13
Patient: female
Reactions: Gastrointestinal Haemorrhage, Trigeminal Neuralgia, RED Blood Cell Abnormality, Disseminated Intravascular Coagulation, Pyrexia, Circulatory Collapse, Staphylococcal Bacteraemia, Melaena, White Blood Cell Count Increased, Hepatitis Fulminant, Hepatosplenomegaly, Mechanical Ventilation, Alanine Aminotransferase Increased, Plasmapheresis, Anaemia, Thrombotic Thrombocytopenic Purpura, Convulsion, Haemodialysis, Haemoglobin Decreased, Renal Impairment, Oliguria, Aspartate Aminotransferase Increased, Blood Smear Test Abnormal, Transfusion, Haemorrhagic Diathesis, Platelet Count Decreased, Altered State of Consciousness, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: unk
Start date: 2007-10-01
End date: 2009-10-28
Tracleer
Dosage: 62.5 mg, bid
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2008-07-10
End date: 2009-09-30
Tracleer
Dosage: 62.5 mg, qd
Administration route: Oral
Start date: 2008-07-02
End date: 2008-07-09
Other drugs received by patient: Carbocisteine; Omeprazole; Sarpogrelate Hydrochloride; Beraprost Sodium; Meloxicam; Trimebutine Maleate
Possible Prednisolone side effects in 36 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-11
Patient: 36 year old male
Reactions: Squamous Cell Carcinoma, Graft Versus Host Disease, Pain of Skin, Nail Growth Abnormal, Bowen's Disease, Skin Papilloma, Skin Lesion, Papilloma Viral Infection, Infection
Drug(s) suspected as cause:
Cyclosporine
Dosage: 30 mg, bid
Indication: Bone Marrow Transplant
Prednisolone
Dosage: 3 mg, daily
Indication: Bone Marrow Transplant
Other drugs received by patient: Imiquimod
Possible Prednisolone side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Prednisolone side effects in
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-05
Patient:
Reactions: Neuropathy Peripheral, Interstitial Lung Disease, Neutropenia, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Doxorubicin HCL
Indication: B-Cell Lymphoma
Neupogen
Indication: B-Cell Lymphoma
Prednisolone
Indication: B-Cell Lymphoma
Rituximab
Dosage: 6 doses-2 days prior to each cycle of chop
Indication: B-Cell Lymphoma
Vincristine
Indication: B-Cell Lymphoma
Possible Prednisolone side effects in 40 year old male
Reported by a individual with unspecified qualification from Germany on 2012-07-03
Patient: 40 year old male
Reactions: Nasopharyngitis, Colitis Ulcerative, Femoral Artery Occlusion, Lipoprotein (A) Increased, Pyrexia, Thromboangiitis Obliterans, Hyperhomocysteinaemia, TOE Amputation, Pain in Extremity, Arterial Thrombosis Limb, Foot Amputation, Hypercoagulation, Acquired Protein S Deficiency, Impaired Healing, Diarrhoea, Hyperfibrinogenaemia, Coagulation Factor Viii Level Increased, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Octagam
Dosage: 10 g (1x 1/d) intravenous (not otherwise specified)
Indication: Infection
Start date: 2011-07-23
End date: 2011-08-13
Prednisolone
Dosage: 50 mg (1x 1/d) oral
Administration route: Oral
Indication: Diarrhoea
Start date: 2011-08-13
End date: 2011-09-23
Other drugs received by patient: Vancomycin; Sulfametthoxazole and Trimethoprim; Omeprazole; Mesalamine; Levofloxacin; Fluconazole
Possible Prednisolone side effects in
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-27
Patient:
Reactions: Angina Pectoris, Death, Ejection Fraction Decreased, Cardiotoxicity, Cardiovascular Disorder, Lymphoma, Myocardial Infarction, Infection
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Lymphoma
Doxorubicin HCL
Dosage: average dose: 336,5 mg/m2 (range 50-680)
Indication: Lymphoma
Prednisolone
Indication: Lymphoma
Vincristine
Indication: Lymphoma
Possible Prednisolone side effects in male
Reported by a physician from Netherlands on 2012-06-25
Patient: male, weighing 84.3 kg (185.5 pounds)
Reactions: Upper-Airway Cough Syndrome, Gastroenteritis, Pyrexia, Pneumococcal Sepsis, Cough, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Aeb071
Dosage: 200 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2009-09-16
Certican
Dosage: 0.25 mg, bid
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-09-07
Prednisolone
Dosage: 5 mg, qd
Administration route: Oral
Indication: Renal Transplant
Start date: 2010-09-07
Possible Prednisolone side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 67 year old male
Reactions: Neutropenia, Infection
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 90 mg/m2, day1-2
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in 30 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 30 year old female
Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Peritonitis, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 54 year old male
Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Infection
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2, day 8
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Etoposide
Dosage: 200 mg/m2, day1-3
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-14
Indication: Chemotherapy
Procarbacin
Dosage: 100 mg/m2, day 1-7
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 49 year old male
Reactions: Neutropenia, Infection
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 90 mg/m2, day1-2
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-5
Indication: Chemotherapy
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Prednisolone side effects in female
Reported by a physician from United Kingdom on 2012-06-15
Patient: female, weighing 46.3 kg (101.9 pounds)
Reactions: Diarrhoea, Bronchopneumonia, Neutropenic Sepsis, Lower Extremity Mass, Oxygen Saturation Decreased, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1150 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Doxorubicin HCL
Dosage: 75 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Mabcampath
Dosage: 30 mg, once on day 1 and 3
Indication: T-Cell Lymphoma
Start date: 2011-12-07
End date: 2012-03-22
Prednisolone
Dosage: 100 mg, day 1-5
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Vincristine Sulfate
Dosage: 2 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Other drugs received by patient: Levothyroxine Sodium; Lansoprazole; Lenograstim; Cotrim; Ondansetron; Domperidone; Valganciclovir; Enoxaparin
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-06-14
Patient: 49 year old male
Reactions: Off Label Use, Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Cyclophosphamide
Doxorubicin HCL
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Prednisolone side effects in 67 year old male
Reported by a physician from Germany on 2012-06-11
Patient: 67 year old male
Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bendamustine
Bendamustine
Indication: Plasmablastic Lymphoma
Bendamustine
Dosage: part of r-chop chemotherapy; later received with bendamustine
Cyclophosphamide
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Cyclosporine
Dosage: 200 milligram;
Indication: Immunosuppressant Drug Therapy
Doxorubicin HCL
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Prednisolone
Dosage: 5 milligram;
Indication: Immunosuppressant Drug Therapy
Prednisone TAB
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Rituximab
Dosage: part of r-chop chemotherapy; later received with bendamustine
Rituximab
Rituximab
Dosage: 2 cycles; followed by r-chop
Indication: Plasmablastic Lymphoma
Vincristine
Dosage: part of r-chop chemotherapy
Indication: Plasmablastic Lymphoma
Other drugs received by patient: Immune Globulin NOS
Possible Prednisolone side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Norway on 2012-06-11
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on d8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650mg/m2 standard cycles 1250 for the escalated cycles
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 35mg/m2,on d1 for escalated cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: 100mg/m2 for the standard cycles d1 to 3; 200mg/m2 for the escalated cycles from d1-3 iv
Indication: Hodgkin's Disease
Prednisolone
Dosage: on days 1 to 14 in every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day1-7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on d8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Germany on 2012-06-08
Patient: 49 year old male
Reactions: Post Transplant Lymphoproliferative Disorder, Plasmablastic Lymphoma, Neutropenia, Infection
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on d1; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Cyclosporine
Dosage: 325 milligram;
Indication: Immunosuppressant Drug Therapy
Doxorubicin HCL
Dosage: on d1; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Prednisolone
Dosage: 100mg, d1-5 of 22d cycle; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Vincristine
Dosage: (max 2mg) on d1; chop-21 chemotherapy
Indication: Plasmablastic Lymphoma
Possible Prednisolone side effects in 84 year old female
Reported by a physician from Japan on 2012-06-08
Patient: 84 year old female, weighing 35.0 kg (77.0 pounds)
Reactions: Respiratory Failure, Cerebral Haemorrhage, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Aspirin
Administration route: Oral
Indication: Cardiac Valve Disease
End date: 2012-04-13
Concentrated RED Cells
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-13
End date: 2012-04-13
Galantamine Hydrobromide
Administration route: Oral
Indication: Dementia Alzheimer's Type
Start date: 2012-02-17
End date: 2012-04-05
Galantamine Hydrobromide
Administration route: Oral
Start date: 2012-04-06
End date: 2012-04-13
Lendormin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Prednisolone
Administration route: Oral
Indication: Lupus Nephritis
End date: 2012-04-13
Warfarin Sodium
Administration route: Oral
Indication: Cardiac Valve Disease
End date: 2012-04-13
Other drugs received by patient: Lasix; Alendronate Sodium; Cotrim; Onealfa; Gasmotin; Rabeprazole Sodium; Strocain
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-06-08
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Possible Prednisolone side effects in 76 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-06
Patient: 76 year old male
Reactions: Malaise, Pyrexia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Chlorambucil (Chlorambucil) (Tablet)
Dosage: 18 milligram (1-2) (1000 milligram (18 milligram, 1 in 1 days), oralq
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-23
Ofatumumab (Ofatumumab)
Dosage: 1000 milligram), intravenous
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-21
Prednisolone
Dosage: 20 milligram (20 milligram, 1 in 1 days), oral
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-23
End date: 2012-04-25
Other drugs received by patient: Bendamustine (Bendamustine); G-CSF (G-Csf); Acetaminophen; Allopurinol; Acyclovir; Chlorpheniramine Maleate; Ranitidine Hydrochloride; Metoclopramide
Possible Prednisolone side effects in 49 year old male
Reported by a physician from Norway on 2012-06-05
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Doxorubicin HCL
Dosage: for escalated cycles on day 1
Doxorubicin HCL
Dosage: for standard cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: for the standard cycles, day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Prednisolone side effects in female
Reported by a physician from United Kingdom on 2012-06-04
Patient: female, weighing 46.3 kg (101.9 pounds)
Reactions: Bronchopneumonia, Oxygen Supplementation, Lymphoma, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1150 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Doxorubicin HCL
Dosage: 75 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Mabcampath
Dosage: 30 mg, once on day 1 and 3
Indication: T-Cell Lymphoma
Start date: 2011-12-07
End date: 2012-03-22
Prednisolone
Dosage: 100 mg, day 1-5
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Vincristine
Dosage: 2 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Other drugs received by patient: Levothyroxine Sodium; Lenograstim; Valganciclovir; Domperidone; Lansoprazole; Enoxaparin; Cotrim; Ondansetron
Possible Prednisolone side effects in 76 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-31
Patient: 76 year old male
Reactions: Malaise, Pyrexia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Leukeran
Dosage: 18 milligram (18 milligram, 1 in 1 days) , oral
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-23
Ofatumumab (Ofatumumab)(unknown)
Dosage: (1000 milligram) intravenous (not otherwise specified)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2012-03-22
Prednisolone
Dosage: 20 milligram (20 milligram,l 1in 1 days) , oral
Administration route: Oral
Start date: 2012-04-23
End date: 2012-04-25
Other drugs received by patient: Chlorpheniramine (Chlorpheniramine)(unknown); Ranitidine; Allopurinol; Bendamustine (Bendamustine)(unknown); Acetaminophen; Metoclopramide; Aciclovir (Aciclovir)(unknown); G-CSF (G-Csf)(unknown)
Possible Prednisolone side effects in female
Reported by a physician from United Kingdom on 2012-05-29
Patient: female, weighing 46.3 kg (101.9 pounds)
Reactions: Death, Metapneumovirus Infection, Hypotension, Cytomegalovirus Infection, Oxygen Supplementation, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1150 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Doxorubicin HCL
Dosage: 75 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Mabcampath
Dosage: 30 mg, once on day 1 and 3
Indication: T-Cell Lymphoma
Start date: 2011-12-07
End date: 2012-03-22
Prednisolone
Dosage: 100 mg, day 1-5
Administration route: Oral
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Vincristine
Dosage: 2 mg, once
Indication: T-Cell Lymphoma
Start date: 2011-11-21
End date: 2012-03-20
Other drugs received by patient: Lansoprazole; Valganciclovir; Levothyroxine Sodium; Motilium; Lenograstim; Ondansetron; Enoxaparin; Cotrim
Page 1 Next >>
|
